Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
TXG — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

14.37

Margin Of Safety %

-37

Put/Call OI Ratio

0.31

EPS Next Q Diff

-1.26

EPS Last/This Y

0.35

EPS This/Next Y

0.21

Price

52.17

Target Price

46.31

Analyst Recom

2.38

Performance Q

132.6

Upside

-114.7%

Beta

2.03

Ticker: TXG




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-13TXG41.780.240.0911352
2026-07-14TXG45.780.230.1911452
2026-07-15TXG45.730.240.2511624
2026-07-16TXG44.510.240.9311567
2026-07-17TXG43.720.260.1511746
2026-07-20TXG43.170.280.139288
2026-07-21TXG47.150.270.279317
2026-07-22TXG47.080.280.739687
2026-07-23TXG48.020.280.129869
2026-07-24TXG46.30.280.219783
2026-07-27TXG45.940.290.519799
2026-07-28TXG47.040.290.219902
2026-07-29TXG46.350.290.699913
2026-07-30TXG49.430.290.479940
2026-07-31TXG47.260.290.3210000
2026-08-03TXG46.990.300.3910012
2026-08-04TXG47.830.300.1510065
2026-08-05TXG47.50.270.7811553
2026-08-06TXG45.540.280.9211651
2026-08-07TXG52.130.312.1312650
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-13TXG41.77-100.0-99.30.00
2026-07-14TXG45.76-100.0-113.60.00
2026-07-15TXG45.72-100.0-101.90.00
2026-07-16TXG44.51-100.0-98.80.00
2026-07-17TXG43.74-100.0-100.00.00
2026-07-20TXG43.19-100.0-100.60.00
2026-07-21TXG47.09-100.0-113.10.00
2026-07-22TXG46.97-100.0-101.50.00
2026-07-23TXG48.10-100.0-104.70.00
2026-07-24TXG46.23-100.0-97.40.00
2026-07-27TXG45.92-100.0-101.10.00
2026-07-28TXG47.02-100.0-104.90.00
2026-07-29TXG46.33-100.0-100.20.00
2026-07-30TXG49.45-100.0-110.20.00
2026-07-31TXG47.27-100.0-96.90.00
2026-08-03TXG46.96-100.0-101.30.00
2026-08-04TXG46.96-100.0-101.30.00
2026-08-05TXG47.51-100.0-101.20.00
2026-08-06TXG45.55-100.0-97.10.00
2026-08-07TXG52.17-100.0-119.70.00
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-13TXG-1.151.3414.45
2026-07-14TXG-1.151.3414.45
2026-07-15TXG-1.151.3414.45
2026-07-16TXG-1.151.3414.45
2026-07-17TXG-1.151.3414.45
2026-07-20TXG-1.151.4014.45
2026-07-21TXG-1.151.4014.45
2026-07-22TXG-1.151.4014.45
2026-07-23TXG-1.151.4014.45
2026-07-24TXG-1.151.4014.45
2026-07-27TXG-1.151.4814.37
2026-07-28TXG-1.151.4814.37
2026-07-29TXG-1.151.4814.37
2026-07-30TXG-1.151.4814.37
2026-07-31TXG-1.151.4814.37
2026-08-03TXG-1.150.5414.37
2026-08-04TXG-1.150.5414.37
2026-08-05TXG-1.150.5414.37
2026-08-06TXG-1.150.5414.37
2026-08-07TXG-1.150.5414.37
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

1.22

Avg. EPS Est. Current Quarter

-0.02

Avg. EPS Est. Next Quarter

-0.04

Insider Transactions

-1.15

Institutional Transactions

0.54

Beta

2.03

Average Sales Estimate Current Quarter

146

Average Sales Estimate Next Quarter

147

Fair Value

32.66

Quality Score

46

Growth Score

39

Sentiment Score

71

Actual DrawDown %

72.7

Max Drawdown 5-Year %

-96.3

Target Price

46.31

P/E

Forward P/E

PEG

P/S

10.73

P/B

8.26

P/Free Cash Flow

54.19

EPS

-0.59

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

0.21

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-12.18

Relative Volume

1.66

Return on Equity vs Sector %

-30.1

Return on Equity vs Industry %

-13.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-119.7
TXG Healthcare
$52.15
📉
Swing / Pullback
Buy the dip on strong trends
39 /100
WEAK
Trend
20/20
Pullback
2/25
Volume
3/15
Valuation
4/20
TP/AR
5/10
Options
5/10
RSI
67.9
Range 1M
96.5%
Sup Dist
14.5%
🚀
Momentum Growth
Ride accelerating trends
N/A
41 /100
WEAK
Momentum
15/25
Growth
4/30
Estimates
5/20
Inst/Vol
10/15
Options
7/10
EPS Yr
-106.3%
EPS NY
6%
52W%
98.6%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🔴 SELL -60.9% upside
Quality
6/30
Valuation
4/30
Growth
6/25
Stability
9/10
LT Trend
4/5
Upside
-60.9%
Quality
46
MoS
-37%
TXG — P/E HistoricalHealth Information Services
10x Genomics, Inc.
Sector: Healthcare
Industry: Health Information Services
Employees: 1178
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
TXG

Latest News

Caricamento notizie per TXG
stock quote shares TXG – 10x Genomics, Inc. Stock Price stock today
news today TXG – 10x Genomics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch TXG – 10x Genomics, Inc. yahoo finance google finance
stock history TXG – 10x Genomics, Inc. invest stock market
stock prices TXG premarket after hours
ticker TXG fair value insiders trading